Unexpected Infection Spikes in a Model of Respiratory Syncytial Virus Vaccination
AbstractRespiratory Syncytial Virus (RSV) is an acute respiratory infection that infects millions of children and infants worldwide. Recent research has shown promise for the development of a vaccine, with a range of vaccine types now in clinical trials or preclinical development. We extend an existing mathematical model with seasonal transmission to include vaccination. We model vaccination both as a continuous process, applying the vaccine during pregnancy, and as a discrete one, using impulsive differential equations, applying pulse vaccination. We develop conditions for the stability of the disease-free equilibrium and show that this equilibrium can be destabilised under certain extreme conditions, even with 100% coverage using an (unrealistic) vaccine. Using impulsive differential equations and introducing a new quantity, the impulsive reproduction number, we showed that eradication could be acheived with 75% coverage, while 50% coverage resulted in low-level oscillations. A vaccine that targets RSV infection has the potential to significantly reduce the overall prevalence of the disease, but appropriate coverage is critical. View Full-Text
Share & Cite This Article
Smith, R.J.; Hogan, A.B.; Mercer, G.N. Unexpected Infection Spikes in a Model of Respiratory Syncytial Virus Vaccination. Vaccines 2017, 5, 12.
Smith RJ, Hogan AB, Mercer GN. Unexpected Infection Spikes in a Model of Respiratory Syncytial Virus Vaccination. Vaccines. 2017; 5(2):12.Chicago/Turabian Style
Smith, Robert J.; Hogan, Alexandra B.; Mercer, Geoffry N. 2017. "Unexpected Infection Spikes in a Model of Respiratory Syncytial Virus Vaccination." Vaccines 5, no. 2: 12.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.